Marrone Bio Innovations’ Amplitude™ Biofungicide is Available for This Growing Season‘s Fight Against White Mold
June 12 2018 - 8:31AM
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a leading
provider of bio-based pest management and plant health products for
agriculture, turf and ornamental and water treatment markets,
announces the availability of the biological fungicide, Amplitude™
for the 2018 growing season. This product uses the same
active ingredient in the recently announced EPA approval of
Stargus™.
Amplitude is based on a new strain of Bacillus
amyloliquefaciens discovered by MBI, with strong performance
against white molds and soil diseases such as Phytophthora and
Rhizoctonia (pink rot and black scurf of potatoes), and Fusarium as
shown in field trials in the U.S., Canada and Europe.
Growers have few choices of active ingredients
that perform well on the group of fungi that cause white molds in
row crops like soybeans, canola, pulses, dry beans, bulb vegetables
and sunflower. AmplitudeTM is the result of MBI’s directed
screening discovery program to find a solution that addresses such
a specific market need. This product is also complementary and
additive to the broad spectrum of diseases covered by MBI’s first
biofungicide, Regalia® Rx , providing a solid one-two punch to
controlling white molds and soil diseases in row crops. MBI is also
testing this Bacillus-based product for seed treatment applications
with key strategic partners.
“We are pleased to provide row crop growers with
another tool to control white molds and soil diseases on a broad
range of large acre crops and tuber and root crops, which have
developed a resistance to conventional products. The high level of
performance of Amplitude means it can be used alone, or in
conjunction with a conventional fungicide to enhance control, build
a solid resistance management program and get better ROI overall,”
said Andre Trepanier, MBI’s Director of Marketing.
MBI’s unique natural product chemistry approach
to product performance is supported by R&D work that
demonstrates the bacterium produces natural compounds, some of
which inhibit bacterial and fungal growth, as well as spore
germination. Tests conducted at MBI’s research and
development lab show that Amplitude® works by colonizing plant root
hairs, stems and other plant surfaces to prevent establishment of
fungal and bacterial pathogens, including Fusarium, Sclerotinia,
Rhizoctonia, Verticillium, Phytophthora and Sclerotium.
Furthermore, the bacteria trigger systemic acquired
resistance and induced systemic responses in the plant, creating a
healthier and stronger plant that wards off diseases, increases
growth and improves yield. MBI has been issued a patent on
the novel strain used in AmplitudeTM.
Field studies have shown good efficacy against
Cercospora leaf spot on sugar beets, and white mold on soybean,
sunflower, beans, and canola, and soil applications on potatoes for
control of Rhizoctonia (Black scurf) and Phytophthora
eurythroseptica (pink rot). Successful field trials have been
conducted in the United States, Mexico, Canada and Europe.
The biofungicide product has been submitted to Canada and Mexico
for approval and the dossier is being prepared for Europe. White
mold (also called Sclerotinia stem rot) is a significant problem in
the North Central soybean production region of the US and in
Canada. This disease varies in incidence and severity from year to
year because of its sensitivity to weather. White mold can
substantially reduce yield, especially when climate and management
practices favor high yield potential. According to the Crop
Protection Network, for every 10 percent increase in the incidence
of white mold observed in a field at the R7 soybean growth stage
(beginning maturity), yield is reduced by two to five bushels per
acre. Canada and Europe grow 10.4 and 11.6 million hectares
of canola (oilseed rape) where white mold is the most serious
disease.
Amplitude is already available in most states
with a few states remaining to be approved. More information is
available on the MBI website at
https://marronebioinnovations.com/ag-products/brand/amplitude/.
About Marrone Bio Innovations
Smart. Natural. Solutions.Marrone Bio
Innovations, Inc. (NASDAQ:MBII) strives to lead the movement to a
more sustainable world through the discovery, development and
promotion of biological products for pest management and plant
health. MBI’s effective and environmentally responsible pest
management solutions help customers operate more sustainably while
uniquely improving plant health and increasing crop yields. MBI’s
currently available commercial products are Regalia®, Grandevo®,
Venerate®, Majestene®, Haven® Stargus™, Amplitude™, Zelto® and
Zequanox®. MBI also distributes Jet-Ag® for Jet Harvest in most
regions of the U.S.
Marrone Bio Innovations is dedicated to pioneering smart
biopesticide solutions that support a better tomorrow for both
farmers, turf managers and consumers around the globe. For more
information, please visit www.marronebio.com.
Marrone Bio Innovations Forward Looking
StatementsThis press release contains forward-looking
statements that involve substantial risks and uncertainties.
All statements, other than statements of historical facts, included
in this press release regarding strategy, future operations and
plans, including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing MBI’s views as of any subsequent date. Examples
of such statements include statements regarding the potential of
Amplitude in the market, market projections, including the
potential benefits of Amplitude, and MBI’s plans for expanding
additional label uses and international expansion. Such
forward-looking statements are based on information available to
the Company as of the date of this release and involve a number of
risks and uncertainties, some beyond the Company's control, that
could cause actual results to differ materially from those
anticipated by these forward-looking statements, including
consumer, regulatory and other factors affecting demand for the
MBI’s products, any difficulty in marketing MBI’s products in its
target markets inside and outside the United States, competition in
the market for pest management products, lack of understanding of
bio-based pest management products by customers and growers.
Additional information that could lead to material changes in MBI’s
performance is contained in its filings with the SEC. MBI is
under no obligation to, and expressly disclaims any responsibility
to, update or alter forward-looking statements contained in this
release, whether as a result of current information, future events
or otherwise.
Marrone Bio Innovations Contacts:Pam Marrone,
CEO and FounderAndre Trepanier, Director of MarketingTelephone: +1
(530) 750-2800Email: Info@marronebio.com
MBI Investor Relations:Greg FalesnikManaging
DirectorMZ Group – MZ North AmericaMain: 949-385-6449
MBII@mzgroup.us
www.mzgroup.us
MBI External Public
Relations:Bryan Spevak Account
Director anthonyBarnum Public Relations Office:
512-387-3703 bryan.spevak@anthonybarnum.com
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Mar 2024 to Apr 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Apr 2023 to Apr 2024